Literature DB >> 18520777

Innate immune-mediated neuronal injury consequent to loss of astrocytes.

Peter J Darlington1, Cornelia Podjaski, Katherine E Horn, Santiago Costantino, Manon Blain, Philippe Saikali, Zhihong Chen, Kenneth Adam Baker, Jia Newcombe, Mark Freedman, Paul W Wiseman, Amit Bar-Or, Timothy E Kennedy, Jack P Antel.   

Abstract

Neuronal injury and loss are recognized features of neuroinflammatory disorders, including acute and chronic encephalitides and multiple sclerosis; destruction of astrocytes has been demonstrated in cases of Rasmussen encephalitis. Here, we show that innate immune cells (i.e. natural killer [NK] and gammadelta T cells) cause loss of neurons from primary human neuron-enriched cultures by destroying the supporting astrocytes. Interleukin 2-activated NK cells caused loss of astrocytes within 1 hour, whereas neurons were lost at 4 hours. Time-lapse imaging indicated that delayed neuron loss was due to early destruction of supporting astrocytes. Selective blocking of astrocyte death with anti-NKG2D antibodies reduced neuron loss, as did blocking of CD54 on astrocytes. gammadelta T cells also induced astrocyte cytotoxicity, leading to subsequent neuronal displacement. In astrocytes, NK cells caused caspase-dependent fragmentation of the intermediate filament proteins glial fibrillary acidic protein and vimentin, whereas anti-CD3-activated T cells produced fragmentation to a lesser extent and without measurable cytotoxicity. Glial fibrillary acidic protein fragmentation was also demonstrated in lysates from chronic multiple sclerosis plaques but not from normal control white matter. These data suggest that non-major histocompatibility complex-restricted immune effector cells may contribute to neuron loss in neuroinflammatory disorders indirectly through injury of glia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520777     DOI: 10.1097/NEN.0b013e3181772cf6

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  The impact of glial activation in the aging brain.

Authors:  Aileen M Lynch; Kevin J Murphy; Brian F Deighan; Julie-Ann O'Reilly; Yuri K Gun'ko; Thelma R Cowley; Rodrigo E Gonzalez-Reyes; Marina A Lynch
Journal:  Aging Dis       Date:  2010-09-04       Impact factor: 6.745

Review 2.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

3.  The CNS as a therapeutic target in multiple sclerosis.

Authors:  Jack P Antel
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

Review 4.  Role of the innate immune system in the pathogenesis of multiple sclerosis.

Authors:  Roopali Gandhi; Alice Laroni; Howard L Weiner
Journal:  J Neuroimmunol       Date:  2010-04-15       Impact factor: 3.478

5.  A selective role of NKG2D in inflammatory and autoimmune diseases.

Authors:  Nadia Guerra; Kathleen Pestal; Tiffany Juarez; Jennifer Beck; Karen Tkach; Lin Wang; David H Raulet
Journal:  Clin Immunol       Date:  2013-09-14       Impact factor: 3.969

6.  Stress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8+ T-Cell Behaviors.

Authors:  Ana Carmena Moratalla; Yves Carpentier Solorio; Florent Lemaitre; Negar Farzam-Kia; Annie Levert; Stephanie E J Zandee; Boaz Lahav; Jean Victor Guimond; Elie Haddad; Marc Girard; Pierre Duquette; Catherine Larochelle; Alexandre Prat; Nathalie Arbour
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-12-06

7.  Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.

Authors:  Peter J Darlington; Brandon Stopnicki; Tarik Touil; Jean-Sebastien Doucet; Lama Fawaz; Morgan E Roberts; Marie-Noëlle Boivin; Nathalie Arbour; Mark S Freedman; Harold L Atkins; Amit Bar-Or
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.